mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.038 |
0.8 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
0.035 |
0.8 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |